A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

Merck stands to lose $62 billion over four years following the loss of exclusivity on KEYTRUDA, making Moderna's $13 billion market cap a bargain. The worsening Avian Flu crisis adds optionality ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

The U.S. government will pay the vaccine maker Moderna $176 million to accelerate development of a pandemic influenza vaccine that could be used to treat bird flu in people, as concern grows about ...

Going out to breakfast with the family? Well, if you plan on going to Waffle House, you’re going to have to pay a little ...